KR20180022430A - Facial mask - Google Patents
Facial mask Download PDFInfo
- Publication number
- KR20180022430A KR20180022430A KR1020160107854A KR20160107854A KR20180022430A KR 20180022430 A KR20180022430 A KR 20180022430A KR 1020160107854 A KR1020160107854 A KR 1020160107854A KR 20160107854 A KR20160107854 A KR 20160107854A KR 20180022430 A KR20180022430 A KR 20180022430A
- Authority
- KR
- South Korea
- Prior art keywords
- weight
- parts
- facial mask
- zinc oxide
- present
- Prior art date
Links
- 230000001815 facial effect Effects 0.000 title claims abstract description 40
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 claims abstract description 40
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 claims abstract description 20
- 239000011787 zinc oxide Substances 0.000 claims abstract description 20
- 238000000034 method Methods 0.000 claims abstract description 9
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 7
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 claims abstract description 7
- 229940116229 borneol Drugs 0.000 claims abstract description 7
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 claims abstract description 7
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 claims abstract description 7
- 241000576429 Forsythia suspensa Species 0.000 claims abstract description 3
- 240000004534 Scutellaria baicalensis Species 0.000 claims abstract description 3
- 235000017089 Scutellaria baicalensis Nutrition 0.000 claims abstract description 3
- 239000000203 mixture Substances 0.000 claims description 33
- 240000004980 Rheum officinale Species 0.000 claims description 20
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 19
- 229910052737 gold Inorganic materials 0.000 claims description 19
- 239000010931 gold Substances 0.000 claims description 19
- 239000000454 talc Substances 0.000 claims description 19
- 229910052623 talc Inorganic materials 0.000 claims description 19
- 241000202807 Glycyrrhiza Species 0.000 claims description 18
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 claims description 18
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims description 18
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 claims description 18
- 229940010454 licorice Drugs 0.000 claims description 18
- 239000003795 chemical substances by application Substances 0.000 claims description 14
- 239000004459 forage Substances 0.000 claims description 12
- 241001165494 Rhodiola Species 0.000 claims description 9
- 239000003242 anti bacterial agent Substances 0.000 claims description 6
- 210000003953 foreskin Anatomy 0.000 claims description 5
- 244000170916 Paeonia officinalis Species 0.000 claims description 3
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 3
- 244000247747 Coptis groenlandica Species 0.000 claims description 2
- 235000002991 Coptis groenlandica Nutrition 0.000 claims description 2
- 241000628997 Flos Species 0.000 claims description 2
- 235000008081 Rheum officinale Nutrition 0.000 claims description 2
- IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 claims description 2
- KNXVOGGZOFOROK-UHFFFAOYSA-N trimagnesium;dioxido(oxo)silane;hydroxy-oxido-oxosilane Chemical compound [Mg+2].[Mg+2].[Mg+2].O[Si]([O-])=O.O[Si]([O-])=O.[O-][Si]([O-])=O.[O-][Si]([O-])=O KNXVOGGZOFOROK-UHFFFAOYSA-N 0.000 claims description 2
- 235000007516 Chrysanthemum Nutrition 0.000 claims 2
- 244000189548 Chrysanthemum x morifolium Species 0.000 claims 2
- 230000003078 antioxidant effect Effects 0.000 claims 2
- 238000013138 pruning Methods 0.000 claims 1
- 239000004615 ingredient Substances 0.000 abstract description 4
- 238000004519 manufacturing process Methods 0.000 abstract description 4
- 239000003814 drug Substances 0.000 abstract description 3
- 230000009286 beneficial effect Effects 0.000 abstract description 2
- 230000017531 blood circulation Effects 0.000 abstract description 2
- 239000002341 toxic gas Substances 0.000 abstract description 2
- 241000037740 Coptis chinensis Species 0.000 abstract 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 abstract 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 abstract 1
- 241001071917 Lithospermum Species 0.000 abstract 1
- 244000167230 Lonicera japonica Species 0.000 abstract 1
- 235000017617 Lonicera japonica Nutrition 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 235000008598 Paeonia lactiflora Nutrition 0.000 abstract 1
- 240000005001 Paeonia suffruticosa Species 0.000 abstract 1
- 235000003889 Paeonia suffruticosa Nutrition 0.000 abstract 1
- 244000193032 Rheum rhaponticum Species 0.000 abstract 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 32
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 18
- 235000017060 Arachis glabrata Nutrition 0.000 description 14
- 244000105624 Arachis hypogaea Species 0.000 description 14
- 235000010777 Arachis hypogaea Nutrition 0.000 description 14
- 235000018262 Arachis monticola Nutrition 0.000 description 14
- 235000020232 peanut Nutrition 0.000 description 14
- 239000010903 husk Substances 0.000 description 12
- 241000234314 Zingiber Species 0.000 description 11
- 235000006886 Zingiber officinale Nutrition 0.000 description 11
- 235000008397 ginger Nutrition 0.000 description 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 10
- 239000002245 particle Substances 0.000 description 10
- 239000007788 liquid Substances 0.000 description 9
- 229910052709 silver Inorganic materials 0.000 description 9
- 239000004332 silver Substances 0.000 description 9
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- MHUWZNTUIIFHAS-CLFAGFIQSA-N dioleoyl phosphatidic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C/CCCCCCCC MHUWZNTUIIFHAS-CLFAGFIQSA-N 0.000 description 8
- 229960004502 levodopa Drugs 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 230000003712 anti-aging effect Effects 0.000 description 6
- 210000002752 melanocyte Anatomy 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 241000208422 Rhododendron Species 0.000 description 5
- 239000000758 substrate Substances 0.000 description 5
- 241000700198 Cavia Species 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- 239000011347 resin Substances 0.000 description 4
- 229920005989 resin Polymers 0.000 description 4
- 241000700199 Cavia porcellus Species 0.000 description 3
- 230000000274 adsorptive effect Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 238000003815 supercritical carbon dioxide extraction Methods 0.000 description 3
- 229940126680 traditional chinese medicines Drugs 0.000 description 3
- 230000002087 whitening effect Effects 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 239000013543 active substance Substances 0.000 description 2
- 230000008021 deposition Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000004043 dyeing Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- JHJLBTNAGRQEKS-UHFFFAOYSA-M sodium bromide Chemical compound [Na+].[Br-] JHJLBTNAGRQEKS-UHFFFAOYSA-M 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 1
- 241000555712 Forsythia Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 208000012641 Pigmentation disease Diseases 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 206010042496 Sunburn Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000003255 anti-acne Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- 238000002845 discoloration Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 238000007490 hematoxylin and eosin (H&E) staining Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- SLCVBVWXLSEKPL-UHFFFAOYSA-N neopentyl glycol Chemical compound OCC(C)(C)CO SLCVBVWXLSEKPL-UHFFFAOYSA-N 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000019612 pigmentation Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- -1 potassium ferricyanide Chemical compound 0.000 description 1
- 238000003672 processing method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 238000010298 pulverizing process Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 239000006163 transport media Substances 0.000 description 1
- 238000009827 uniform distribution Methods 0.000 description 1
- 239000002912 waste gas Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D44/00—Other cosmetic or toiletry articles, e.g. for hairdressers' rooms
- A45D44/002—Masks for cosmetic treatment of the face
-
- A—HUMAN NECESSITIES
- A45—HAND OR TRAVELLING ARTICLES
- A45D—HAIRDRESSING OR SHAVING EQUIPMENT; EQUIPMENT FOR COSMETICS OR COSMETIC TREATMENTS, e.g. FOR MANICURING OR PEDICURING
- A45D44/00—Other cosmetic or toiletry articles, e.g. for hairdressers' rooms
- A45D44/22—Face shaping devices, e.g. chin straps; Wrinkle removers, e.g. stretching the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/0212—Face masks
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/27—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Chemical & Material Sciences (AREA)
- Inorganic Chemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Abstract
Description
본 발명은, 피부 케어 분야에 관한 것이고, 구체적으로 페이셜 마스크 분야에 관한 것이다. The present invention relates to the field of skin care, and more particularly to the field of facial masks.
얼굴은, 다른 신체 부위에 비해 주변 환경에 보다 쉽게 노출되고, 따라서 보다 자주 바람, 일광화상, 전자기선, 먼지 등에 의해 야기되는 충격으로부터 고통받는다. 상이한 사람들의 다양한 피부 특성 때문에, 일부 얼굴의 문제들이 발생할 수도 있고, 여기에 포함되는 사람들은 창피하거나 불편함을 느낄 수도 있다. 보다 심각하게는, 이러한 문제들은 사람들의 직업, 결혼 등에 부정적인 영향을 미칠 수도 있다. The face is more easily exposed to the surrounding environment than other body parts, and therefore more often suffers from impacts caused by wind, sunburn, electronic steam, dust, and the like. Due to the diverse skin characteristics of different people, some facial problems may arise, and the people involved may feel embarrassed or uncomfortable. More seriously, these problems may have a negative impact on people's occupations, marriage, and so on.
페이셜 마스크는, 얼굴의 문제들을 완화 또는 제거하는 데에 매우 대중적이다. 그러나, 대부분의 페이셜 마스크는 중금속 또는 인광물질(phosphor) 분말 성분을 함유하며, 이는, 이러한 페이셜 마스크를 장기간 사용하는 경우, 사람들의 피부를 손상시킬 수도 있다. Facial masks are very popular for alleviating or eliminating facial problems. However, most facial masks contain heavy metal or phosphor powder components, which can damage people's skin when such facial masks are used for extended periods of time.
따라서, 장시간 사용에 적합하면서, 피부에 대한 상처를 줄이기 위해서, 천연이면서 안전한 성분을 포함하는 페이셜 마스크를 개발하는 것이 필요하다.Therefore, it is necessary to develop a facial mask containing a natural and safe ingredient in order to be suitable for prolonged use and to reduce the wound on the skin.
본 발명의 목적은 얼굴 케어에 효과적이고 안전한 페이셜 마스크를 제공하는 것이다. It is an object of the present invention to provide an effective and safe facial mask for facial care.
본 발명의 한가지 양태에 따르면, 약용대황(rheum officinale) 10 내지 20중량부, 중국개나리(Forsythia suspensa Vahl) 10 내지 20중량부, 황련(goldthread) 20 내지 30중량부, 황금(Scutellaria baicalensis) 25 내지 40중량부, 감초 10 내지 20중량부, 자초(radix lithospermi) 20 내지 30중량부, 보르네올 20 내지 30중량부, 금은화(FLOS LONICERAE) 20 내지 30중량부, 모란의 뿌리 껍질(root bark of the peony tree) 10 내지 20중량부, 적작약(radix paeoniae rubrathe) 20 내지 40중량부, 활석 분필(French chalk) 20 내지 40중량부, 볼루스 알바(bolus alba) 10 내지 20중량부, 아연 옥사이드 10 내지 20중량부를 포함하는, 페이셜 마스크 조성물이 제공된다. According to one aspect of the present invention there is provided a pharmaceutical composition comprising 10-20 parts by weight of rheum officinale, 10-20 parts by weight Forsythia suspensa Vahl, 20-30 parts by weight goldthread, 25-30 parts by weight Scutellaria baicalensis, 20 to 30 parts by weight of radix lithospermi, 20 to 30 parts by weight of borneol, 20 to 30 parts by weight of FLOS LONICERAE, 20 to 30 parts by weight of root bark of the peony 10 to 20 parts by weight of a peony tree, 20 to 40 parts by weight of radix paeoniae rubrathe, 20 to 40 parts by weight of French chalk, 10 to 20 parts by weight of bolus alba, ≪ / RTI > 20 parts by weight of the composition.
본 발명의 유익한 효과는, 전통 중국 약재의 원료가 서로 상호작용하여 상승 효과를 발휘할 수도 있다는 점, 얼굴의 혈액순환이 가속화될 수 있다는 점 및 노폐물 및 독가스가 흡수될 수 있다는 점이다. The beneficial effect of the present invention is that the raw materials of traditional Chinese medicines may interact with each other and exhibit a synergistic effect, that the blood circulation in the face can be accelerated, and waste and poison gas can be absorbed.
전통 중국 약재 페이셜 마스크는, 영양 및 효과적인 물질들이 피부의 심층을 통과하는 것을 용이하게 하고, 추가로 수분보유, 피부 모이스쳐링, 화이트닝, 주근깨 해소, 주름 방지, 안티-에이징, 소염, 독소-제거, 및 안티-애크니(anti-acne) 측면에서 역할을 한다. Traditional Chinese medicinal facial masks make it easy to pass nutrient and effective substances through the deep layers of the skin and provide additional moisture retention, skin moisturizing, whitening, freckle relief, anti wrinkle, anti-aging, anti- And anti-acne. ≪ / RTI >
추가로, 본 발명에 의해 제공된 페이셜 마스크 내의 다양한 성분들은 상호작용할 수도 있으며, 이는 결과적으로 긴 품질 보증 기간을 유발할 수도 있다. In addition, the various components in the facial mask provided by the present invention may interact, which may result in a long warranty period.
마지막으로, 본 발명에 의해 제공되는 페이셜 마스크는, 단지 천연 식물을 함유하며, 어떠한 화학 성분들도 포함하지 않는다. 따라서, 본 발명은 사람들의 피부에 대해 건강하며 여기에 적은 상처를 준다. Finally, the facial mask provided by the present invention contains only natural plants and does not contain any chemical components. Thus, the present invention is healthy for the skin of people and gives less damage to the skin.
본 발명의 실시양태Embodiments of the present invention
하기 실시예는, 본 발명의 범주 내의 실시양태들을 추가로 기술하고 설명한다. 실시예는, 본 발명의 진의 및 범주로부터 벗어나지 않으면서 그의 많은 변형이 가능하기 때문에, 단지 설명할 목적을 위해 제공되며, 본 발명의 제한으로서 해석되지 않아야 한다.The following examples further describe and describe embodiments within the scope of the present invention. The embodiments are provided for illustrative purposes only and are not to be construed as limitations of the present invention, as many variations thereof are possible without departing from the spirit and scope of the present invention.
본 발명의 한가지 양태에 따르면, 약용대황 10 내지 20중량부, 중국개나리 10 내지 20중량부, 황련 20 내지 30중량부, 황금 25 내지 40중량부, 감초 10 내지 20중량부, 자초 20 내지 30중량부, 보르네올 20 내지 30중량부, 금은화 20 내지 30중량부, 모란의 뿌리 껍질 10 내지 20중량부, 적작약 20 내지 40중량부, 활석 분필 20 내지 40중량부, 볼루스 알바 10 내지 20중량부, 아연 옥사이드 10 내지 20중량부를 포함하는 페이셜 마스크 조성물을 제공한다.According to one aspect of the present invention, there is provided a medicinal composition comprising 10 to 20 parts by weight of medicinal rhubarb, 10 to 20 parts by weight of Chinese forages, 20 to 30 parts by weight of Rhododendron, 25 to 40 parts by weight of gold, 10 to 20 parts by weight of licorice, 20 to 40 parts by weight of talc, 20 to 40 parts by weight of talc, 10 to 20 parts by weight of borosalba, 20 to 30 parts by weight of boronol, 20 to 30 parts by weight of silver, 20 to 40 parts by weight of peanut root husks, And 10 to 20 parts by weight of zinc oxide.
본 발명의 제 1 실시양태에 따르면, 페이셜 마스크 조성물은, 약용대황 10중량부, 중국개나리 10중량부, 황련 20중량부, 황금 25중량부, 감초 10중량부, 자초 20중량부, 보르네올 20중량부, 금은화 20중량부, 모란의 뿌리 껍질 10중량부, 적작약 20중량부, 활석 분필 20중량부, 볼루스 알바 10중량부, 아연 옥사이드 10중량부를 포함한다. According to the first embodiment of the present invention, the facial mask composition comprises 10 parts by weight of medicinal rhubarb, 10 parts by weight of Chinese forages, 20 parts by weight of Rhodiola, 25 parts by weight of gold, 10 parts by weight of licorice, 10 parts by weight of peanut shell, 20 parts by weight of the peel shell, 20 parts by weight of talc, 10 parts by weight of bolus alba, and 10 parts by weight of zinc oxide.
본 발명의 제 2 실시양태에 따르면, 페이셜 마스크 조성물은, 약용대황 20중량부, 중국개나리 20중량부, 황련 30중량부, 황금 40중량부, 감초 120중량부, 자초 30중량부, 보르네올 30중량부, 금은화 30중량부, 모란의 뿌리 껍질 20중량부, 적작약 40중량부, 활석 분필 40중량부, 볼루스 알바 20중량부, 아연 옥사이드 20중량부를 포함한다.According to a second embodiment of the present invention, the facial mask composition comprises 20 parts by weight of medicinal rhubarb, 20 parts by weight of Chinese forsythia, 30 parts by weight of Rhodiola, 40 parts by weight of gold, 120 parts by weight of licorice, 30 parts by weight of ginger silver, 20 parts by weight of peanut root husk, 40 parts by weight of anti-peel agent, 40 parts by weight of talc chalk, 20 parts by weight of bolus alba, and 20 parts by weight of zinc oxide.
본 발명의 제 3 실시양태에 따르면, 페이셜 마스크 조성물은, 약용대황 10중량부, 중국개나리 20중량부, 황련 20중량부, 황금 40중량부, 감초 10중량부, 자초 30중량부, 보르네올 20중량부, 금은화 30중량부, 모란의 뿌리 껍질 10중량부, 적작약 40중량부, 활석 분필 20중량부, 볼루스 알바 20중량부, 아연 옥사이드 10중량부를 포함한다.According to a third embodiment of the present invention, the facial mask composition comprises 10 parts by weight of medicinal rhubarb, 20 parts by weight of Chinese foreskin, 20 parts by weight of Rhodiola, 40 parts by weight of gold, 10 parts by weight of licorice, 30 parts by weight of ginger silver, 10 parts by weight of peanut root husk, 40 parts by weight of the specific agent, 20 parts by weight of talc chalk, 20 parts by weight of bolus alba, and 10 parts by weight of zinc oxide.
본 발명의 제 4 실시양태에 따르면, 페이셜 마스크 조성물은, 약용대황 20중량부, 중국개나리 10중량부, 황련 30중량부, 황금 25중량부, 감초 20중량부, 자초 20중량부, 보르네올 30중량부, 금은화 20중량부, 모란의 뿌리 껍질 20중량부, 적작약 20중량부, 활석 분필 40중량부, 볼루스 알바 10중량부, 아연 옥사이드 20중량부를 포함한다.According to a fourth embodiment of the present invention, the facial mask composition comprises 20 parts by weight of medicinal rhubarb, 10 parts by weight of Chinese forages, 30 parts by weight of Rhododendron, 25 parts by weight of gold, 20 parts by weight of licorice, 20 parts by weight of shoot, 20 parts by weight of ginger powder, 20 parts by weight of peanut root husk, 20 parts by weight of anti-aging agent, 40 parts by weight of talc chalk, 10 parts by weight of Bolus alba, and 20 parts by weight of zinc oxide.
본 발명의 제 5 실시양태에 따르면, 페이셜 마스크 조성물은, 약용대황 15중량부, 중국개나리 15중량부, 황련 25중량부, 황금 32.5중량부, 감초 15중량부, 자초 25중량부, 보르네올 25중량부, 금은화 25중량부, 모란의 뿌리 껍질 15중량부, 적작약 30중량부, 활석 분필 30중량부, 볼루스 알바 15중량부, 아연 옥사이드 15중량부를 포함한다.According to a fifth embodiment of the present invention, the facial mask composition comprises 15 parts by weight of medicinal rhubarb, 15 parts by weight of Chinese forages, 25 parts by weight of Rhodiola, 32.5 parts by weight of gold, 15 parts by weight of licorice, 25 parts by weight of boronol, 25 parts by weight of ginger silver, 15 parts by weight of peanut root husk, 30 parts by weight of anti-aging agent, 30 parts by weight of talc chalk, 15 parts by weight of bolus alba and 15 parts by weight of zinc oxide.
본 발명의 제 6 실시양태에 따르면, 페이셜 마스크 조성물은, 약용대황 10중량부, 중국개나리 15중량부, 황련 20중량부, 황금 32.5중량부, 감초 10중량부, 자초 25중량부, 보르네올 20중량부, 금은화 25중량부, 모란의 뿌리 껍질 10중량부, 적작약 20중량부, 활석 분필 30중량부, 볼루스 알바 10중량부, 아연 옥사이드 15중량부를 포함한다.According to a sixth embodiment of the present invention, the facial mask composition comprises 10 parts by weight of medicinal rhubarb, 15 parts by weight of Chinese forages, 20 parts by weight of Rhodiola, 32.5 parts by weight of gold, 10 parts by weight of licorice, 25 parts by weight of ginger silver, 10 parts by weight of peanut root husk, 20 parts by weight of anti-aging agent, 30 parts by weight of talc chalk, 10 parts by weight of Bolus alba, and 15 parts by weight of zinc oxide.
본 발명의 제 7 실시양태에 따르면, 페이셜 마스크 조성물은, 약용대황 20중량부, 중국개나리 10 내지 20중량부, 황련 30중량부, 황금 32.5중량부, 감초 20중량부, 자초 25중량부, 보르네올 30중량부, 금은화 25중량부, 모란의 뿌리 껍질 20중량부, 적작약 30중량부, 활석 분필 40중량부, 볼루스 알바 15중량부, 아연 옥사이드 20중량부를 포함한다.According to a seventh embodiment of the present invention, the facial mask composition comprises 20 parts by weight of medicinal rhubarb, 10 to 20 parts by weight of Chinese forages, 30 parts by weight of Rhodiola, 32.5 parts by weight of gold, 20 parts by weight of licorice, 30 parts by weight of neol, 25 parts by weight of gold and silver, 20 parts by weight of peanut root shell, 30 parts by weight of antibacterial agent, 40 parts by weight of talc chalk, 15 parts by weight of bolus alba and 20 parts by weight of zinc oxide.
본 발명의 제 8 실시양태에 따르면, 페이셜 마스크 조성물은, 약용대황 15중량부, 중국개나리 10중량부, 황련 25중량부, 황금 25중량부, 감초 15중량부, 자초 20중량부, 보르네올 25중량부, 금은화 20중량부, 모란의 뿌리 껍질 15중량부, 적작약 20중량부, 활석 분필 30중량부, 볼루스 알바 10중량부, 아연 옥사이드 15중량부를 포함한다.According to an eighth embodiment of the present invention, the facial mask composition comprises 15 parts by weight of medicinal rhubarb, 10 parts by weight of Chinese forages, 25 parts by weight of Rhodiola, 25 parts by weight of gold, 15 parts by weight of licorice, 20 parts by weight of shoot, 20 parts by weight of ginger silver, 15 parts by weight of peanut root husk, 20 parts by weight of anti-aging agent, 30 parts by weight of talc chalk, 10 parts by weight of bolus alba, and 15 parts by weight of zinc oxide.
본 발명의 제 9 실시양태에 따르면, 페이셜 마스크 조성물은, 약용대황 15중량부, 중국개나리 20중량부, 황련 25중량부, 황금 40중량부, 감초 15중량부, 자초 30중량부, 보르네올 25중량부, 금은화 30중량부, 모란의 뿌리 껍질 15중량부, 적작약 40중량부, 활석 분필 30중량부, 볼루스 알바 20중량부, 아연 옥사이드 15중량부를 포함한다.According to a ninth embodiment of the present invention, the facial mask composition comprises 15 parts by weight of medicinal rhubarb, 20 parts by weight of Chinese foreskin, 25 parts by weight of Rhodiola, 40 parts by weight of gold, 15 parts by weight of licorice, 30 parts by weight of ginger silver, 15 parts by weight of peanut root husk, 40 parts by weight of potato peel, 30 parts by weight of talc chalk, 20 parts by weight of bolus alba and 15 parts by weight of zinc oxide.
본 발명의 제 10 실시양태에 따르면, 페이셜 마스크 조성물은, 약용대황 12중량부, 중국개나리 13중량부, 황련 24중량부, 황금 28중량부, 감초 19중량부, 자초 21중량부, 보르네올 23중량부, 금은화 26중량부, 모란의 뿌리 껍질 18중량부, 적작약 32중량부, 활석 분필 35중량부, 볼루스 알바 17중량부, 아연 옥사이드 16중량부를 포함한다.According to a tenth embodiment of the present invention, the facial mask composition comprises 12 parts by weight of medicinal rhubarb, 13 parts by weight of Chinese foreskin, 24 parts by weight of phthalocyanine, 28 parts by weight of gold, 19 parts by weight licorice, 21 parts by weight of boronol 26 parts by weight of ginger iron, 18 parts by weight of peanut root husk, 32 parts by weight of anti-aging agent, 35 parts by weight of talc chalk, 17 parts by weight of Bolus alba, and 16 parts by weight of zinc oxide.
본 발명의 제 11 실시양태에 따르면, 페이셜 마스크 조성물은, 약용대황 12중량부, 중국개나리 11중량부, 황련 14중량부, 황금 28중량부, 감초 16중량부, 자초 24중량부, 보르네올 27중량부, 금은화 26중량부, 모란의 뿌리 껍질 16중량부, 적작약 33중량부, 활석 분필 28중량부, 볼루스 알바 14중량부, 아연 옥사이드 13중량부를 포함한다.According to an eleventh embodiment of the present invention, the facial mask composition comprises 12 parts by weight of medicinal rhubarb, 11 parts by weight of Chinese forages, 14 parts by weight of Rhododendron, 28 parts by weight of gold, 16 parts by weight of licorice, 24 parts by weight of boronol 26 parts by weight of ginger iron, 16 parts by weight of peanut root husk, 33 parts by weight of antibacterial agent, 28 parts by weight of talc chalk, 14 parts by weight of bolus alba and 13 parts by weight of zinc oxide.
본 발명의 제 12 실시양태에 따르면, 페이셜 마스크 조성물은, 약용대황 12중량부, 중국개나리 18중량부, 황련 22중량부, 황금 38중량부, 감초 14중량부, 자초 26중량부, 보르네올 28중량부, 금은화 22중량부, 모란의 뿌리 껍질 15중량부, 적작약 25중량부, 활석 분필 22중량부, 볼루스 알바 18중량부, 아연 옥사이드 17중량부를 포함한다.According to a twelfth embodiment of the present invention, the facial mask composition comprises 12 parts by weight of medicinal rhubarb, 18 parts by weight of Chinese forages, 22 parts by weight of Rhododendron, 38 parts by weight of gold, 14 parts by weight of licorice, 26 parts by weight of boronol, 22 parts by weight of ginger silver, 15 parts by weight of peanut root husk, 25 parts by weight of antibacterial agent, 22 parts by weight of talc chalk, 18 parts by weight of bolus alba, and 17 parts by weight of zinc oxide.
본 발명의 제 13 실시양태에 따르면, 페이셜 마스크 조성물은, 약용대황 16중량부, 중국개나리 14중량부, 황련 21중량부, 황금 39중량부, 감초 14중량부, 자초 26중량부, 보르네올 24중량부, 금은화 26중량부, 모란의 뿌리 껍질 12중량부, 적작약 28중량부, 활석 분필 32중량부, 볼루스 알바 18중량부, 아연 옥사이드 13중량부를 포함한다.According to a thirteenth embodiment of the present invention, the facial mask composition comprises 16 parts by weight of medicinal rhubarb, 14 parts by weight of Chinese forages, 21 parts by weight of Rhododendron, 39 parts by weight of gold, 14 parts by weight of licorice, 26 parts by weight of boronol 26 parts by weight of ginger iron, 12 parts by weight of peanut root husk, 28 parts by weight of antibacterial agent, 32 parts by weight of talc chalk, 18 parts by weight of Bolus alba, and 13 parts by weight of zinc oxide.
"중량부"란 용어는, 각각의 성분들 또는 구성요소들 사이의 비를 의미하지만 전체 중량에 대한 백분률을 의미하는 것은 아님을 언급할 필요가 있다. It is to be noted that the term "part by weight " means the ratio between the individual components or components but does not imply a percentage of the total weight.
제조 방법Manufacturing method
전술한 재료 또는 성분들은 시장에서 상업적으로 입수가능하거나, 통상적인 가공 방법에 의해 수득될 수 있다, 예를 들어, 이러한 재료들은 상기 재료들을, 건조하고 평균 입경이 20 내지 30메쉬인 범위의 분말로 분쇄함으로써 수득될 수 있다. The above-mentioned materials or ingredients are commercially available on the market or can be obtained by conventional processing methods. For example, these materials can be obtained by drying the above materials in powders in the range of 20 to 30 mesh average particle size Followed by pulverization.
전통 중국 약재 추출물의 제조는, 하기 과정을 포함한다.The manufacture of traditional Chinese medicinal plant extracts includes the following processes.
개별적인 성분들을 혼합하고 분말로 분쇄하고, 용매로서 에탄올을 사용하여, 0.5시간 동안 60℃ 및 30Mpa 하에서 상기 분말에 대해 초임계 이산화탄소 추출을 시행한다. 구체적으로, 에탄올의 양은 상기 분말의 그램 당 2ml이고, 분석 압력은 10MPa이고, 분석 온도는 20℃이다.The individual components are mixed and ground into a powder and supercritical carbon dioxide extraction is performed on the powder at 60 DEG C and 30 MPa for 0.5 hour using ethanol as solvent. Specifically, the amount of ethanol is 2 ml per gram of the powder, the analytical pressure is 10 MPa, and the analysis temperature is 20 占 폚.
감압 농축을 수행하고, 에탄올을 회수하여, 에탄올 추출 농축물을 수득한다. Concentration under reduced pressure is performed, and ethanol is recovered to obtain an ethanol extract concentrate.
초임계 이산화탄소 추출을 시행한 이후에, 잔류물을 2회 끓이되, 여기서 처음에는 잔류물을 8 내지 10배의 물과 함께 30 내지 50분 동안 끓이고; 두번째는, 상기 잔류물을 9 내지 12배의 물과 함께 80 내지 90분 동안 끓인다. After performing the supercritical carbon dioxide extraction, the residue is boiled twice, wherein the residue is first boiled with 8 to 10 times water for 30 to 50 minutes; Second, the residue is boiled with 9 to 12 times water for 80 to 90 minutes.
끓인 액체를 여과하고 여과된 액체를 모으고, 그다음 이것을, 50℃에서 밀도가 1.3 내지 1.5인 액체로 농축한다. The boiled liquid is filtered and the filtered liquid is collected, which is then concentrated to a liquid having a density of 1.3 to 1.5 at 50 ° C.
밀도가 1.3 내지 1.5인 액체를 건조하여 추출물을 수득한다. A liquid having a density of 1.3 to 1.5 is dried to obtain an extract.
상기 추출물을 거대다공성 흡착성 수지로 강화하는데, 구체적으로, 상기 추출물을 특정량의 물로 희석하고, 동일한 체적의 D-101 거대다공성 흡착성 수지와 혼합하고, D-101 또는 AB-8 타입 및 기타 비-극성, 약한 극성 또는 중간 극성의 거대다공성 흡착성 수지 위에 담지한다. 담지 체적은, 생산 체적 대 수지 사이의 1:3의 비로 계산한다. 15분의 정적 흡착 이후에, 상이한 밀도를 갖는, 10배의 에탄올을 사용하여 용리하고, 에탄올 용리액의 60 내지 70%를 수집하여, 갈색 분말을 수득한다. Specifically, the extract is diluted with a certain amount of water, mixed with the same volume of D-101 macroporous adsorptive resin, mixed with D-101 or AB-8 type and other non-porous adsorptive resins, Polar, weakly polar or medium polarity macroporous adsorptive resin. The supported volume is calculated by a ratio of 1: 3 between the production volume and the resin. After 15 minutes of static adsorption, elution is carried out with 10 times of ethanol, with different densities, and 60 to 70% of the ethanol eluate is collected, yielding a brown powder.
추가로, 초임계 이산화탄소 추출을 통해 수득된 갈색의 오일-유사 점액과 상기 분말을 혼합하고, 이로써 전통 중국 약재 추출액을 수득한다. In addition, the powder is mixed with the brown oil-like mucilage obtained through supercritical carbon dioxide extraction, thereby obtaining a traditional Chinese medicinal extract.
UVB에 의해 유도된 색소 침착(pigmentation) 모델을 사용하고 전통 중국 약재를 하기와 같이 투여한다. Using a UVB-induced pigmentation model and administering traditional Chinese medicines as follows.
각각의 기니아 피그의 등 위에 3개의 분리된 영역(2cm×2cm)을 선택하고 각각의 기니아 피그의 등의 긴 털을 가위로 자르고 짧은 털은 전기 면도기로 제거한다. 그다음, 상기 영역을, 310 내지 315nm의 스펙트럼 피크를 갖는 UVB 광원이 장착된 SS-04B 유형의 광선 장치로 조사한다. 상기 영역을 매일 20분 동안 200mJ/㎠의 양으로 조사하고, 상기 조사를 2주 동안 지속하여 2800mJ/㎠의 축적 조사량을 수득한다. 조사를 완료한 2시간 이후에 약재를 투여하고, 약재 투여는, 조사를 마친 이후에 2주 동안 지속한다. 그다음, 얼굴 조직에 대해 병리학적 검사를 시행한다. Three separate areas (2 cm x 2 cm) are selected on the back of each guinea pig, the long hair of each guinea pig is cut with scissors, and the short hair is removed with an electric shaver. The region is then illuminated with a light beam device of the SS-04B type equipped with a UVB light source having a spectral peak of 310 to 315 nm. The area is irradiated in an amount of 200 mJ / cm2 for 20 minutes every day, and the irradiation is continued for 2 weeks to obtain an accumulated irradiation amount of 2800 mJ / cm2. The medication is administered 2 hours after the completion of the study and the medication is continued for 2 weeks after completion of the study. Then, pathological examination is performed on the facial tissue.
멜라닌-함유 세포 및 DOPA 양성 세포의 갯수를 관찰하기 위해서, 샘플을 3개의 그룹으로 나눈다. To observe the number of melanin-containing and DOPA-positive cells, the samples are divided into three groups.
그룹 1: UVB에 의해 조사되지 않은 일반 기니아 피그의 등 피부를 포함하는 기준 그룹;Group 1: a reference group comprising the back skin of common guinea pigs not irradiated by UVB;
그룹 2: UVB에 의해 조사되지만, 본 발명의 전통 중국 약재로 코팅되지 않은 기니아 피그의 등 피부를 포함하는 그룹;Group 2: a group comprising the back skin of guinea pigs, which is irradiated by UVB but not coated with traditional Chinese medicinal materials of the present invention;
그룹 3: UVB 조사 이후에, 각각 농도가 0.5 및 1mg/ml인 실시양태 1 내지 13의 전통 중국 약재로 코팅된 기니아 피그의 등 피부를 포함하는 그룹.Group 3: A group comprising the back skin of guinea pigs coated with the traditional Chinese medicines of Examples 1 to 13, respectively, at concentrations of 0.5 and 1 mg / ml after UVB irradiation.
염색 공정Dyeing process
1）HE 염색: 기니아 피그의 등의 피부 샘플(2cm×2cm)을 통상적인 파라핀 섹션으로 HE-염색한다.1) HE staining: Skin samples (2 cm x 2 cm) of the back of guinea pigs are HE-stained with a conventional paraffin section.
2）슈몰(schmor) 염색:2) Schmor staining:
a. 섹션을 물로 세정한다; a. The sections are rinsed with water;
b. 그다음, 상기 섹션을 10분 동안, 0.04mol/L의 농도의 40ml의 FeCl3, 0.04mol/L의 농도의 6ml의 페리시안화 칼륨, 및 6ml의 증류수로 가공한다; b. The section is then processed for 10 minutes with 40 ml of FeCl 3 at a concentration of 0.04 mol / L, 6 ml of potassium ferricyanide at a concentration of 0.04 mol / L, and 6 ml of distilled water;
c. 그다음, 상기 섹션을 흐르는 물로 세정한다. c. Then, the section is rinsed with running water.
결과: 멜라닌 세포를 갈색, 흑색 입자로 염색한다. Results: Melanocytes were stained with brown and black particles.
3) 이모가와(Imokawa) 염색3) Imokawa dyeing
a. 기니아 피그의 등으로부터 피부 샘플(2cm×2cm)을 취하고, 0.1mol/L의 농도(PH6.8)의 PBS 액체로 세정하고, 그다음 5시간 동안 37℃에서 1mol/L 농도의 브롬화 나트륨과 함께 인큐베이션한다. a. A skin sample (2 cm x 2 cm) was taken from the back of a guinea pig, washed with PBS liquid at a concentration of 0.1 mol / L (PH6.8), incubated for 5 hours at 37 DEG C with sodium bromide at a concentration of 1 mol / do.
b. 피부의 진피 및 큐티클을 분리한다.b. Separate the dermis and cuticle of the skin.
c. 상기 큐티클은, 30분 동안 3.33mol/L(10%)의 농도의 냉각된 중성 포르말린 용액으로 조절하고(regulate), 그다음 2회 0.1mol/L(PH6.8)의 농도의 PBS 용액으로 세정한다. c. The cuticle is regulated with a cold neutral formalin solution at a concentration of 3.33 mol / L (10%) for 30 minutes and then washed twice with a PBS solution at a concentration of 0.1 mol / L (PH6.8) .
d. 그다음, 큐티클은, 5시간 동안 0.1mol/L의 농도의 PBS 용액으로 염색한다. d. The cuticle is then stained with a PBS solution at a concentration of 0.1 mol / L for 5 hours.
결과: 멜라닌 세포를 흑색 및 갈색 입자로 염색한다.Results: Melanocytes were stained with black and brown particles.
광학 현미경 관찰Optical microscope observation
·멜라닌 입자 세포의 계수: 슈몰 염색을 진행하고, 각각의 샘플의 큐티클 기판의 mm2 당 멜라닌 입자 세포의 갯수를, 고배율 렌즈 밑에서 순수 접안 마이크로미터 단일 맹검법으로 계수한다. ;Count of Melanin Particle Cells: Proceed with the minocompression and count the number of melanin particles per mm 2 of the cuticle substrate of each sample by a pure eyepiece micrometer single blind method under the high magnification lens. ;
·DOPA 양성 세포의 계수: 이모가와 염색을 진행하고, 각각의 샘플의 큐티클 기판의 mm2 당 DOPA 양성 멜라닌 세포의 갯수를, 고배율 렌즈 밑에서 순수 접안(net eyepiece) 마이크로미터 단일 맹검법으로 계수한다.DOPA positive cell counts: The number of DOPA positive melanocytes per mm 2 of the cuticle substrate of each sample was counted by a simple eyepiece micrometer single-blind method under a high magnification lens .
표 1은, 조사하지 않은 그룹, 조사하지 않은 그룹, 및 본 발명의 실시양태 1 내지 13에 따른 페이셜 마스크를 도포한 그룹과 관련하여, 멜라닌 입자 세포 및 DOPA 양성 멜라닌 세포의 평균 갯수를 나타낸다. Table 1 shows the average number of melanin particle and DOPA positive melanocyte cells in relation to the unexposed group, the unexposed group, and the group to which the facial mask was applied according to Embodiments 1 to 13 of the present invention.
기준 그룹과 비교시, UVB 조사 하에 노출된 제 2 그룹은, 매우 많은 수의 멜라닌 입자 세포 및 DOPA 양성 멜라닌 세포를 가졌다. Compared with the reference group, the second group exposed under UVB irradiation had a very large number of melanin particles and DOPA positive melanocytes.
본 발명의 실시양태 1 내지 13으로 도포한 이후에, 큐티클의 DOPA 양성 멜라닌 세포 및 멜라닌 입자 세포의 갯수는, 기준 그룹에 매우 근접한 수준으로 유의하게 감소하였다. 명맥하게, 본 발명은, 피부 화이트닝 및 갈색반 제거에 대해 우수한 효과를 나타낸다. After application of Embodiments 1 to 13 of the present invention, the number of cutaneous DOPA positive melanin cells and melanin particle cells was significantly reduced to a level very close to the reference group. Clearly, the present invention exhibits excellent effects on skin whitening and brownish discoloration.
특히, 실시양태 5는, 멜라닌 입자 세포 및 DOPA 양성 멜라닌 세포의 갯수를 줄이는 것에 실시양태 1 내지 13 중에서 가장 우수한 효과를 나타내며, 종종 이 실시양태는 기준 그룹에 매우 근접한 수준에 도달한다. In particular, Embodiment 5 shows the best effect among Embodiments 1 to 13 in reducing the number of melanin particle cells and DOPA positive melanin cells, and often this embodiment reaches a level very close to the reference group.
추가로, 실시양태 1, 11 및 12는 또한 실시양태 1를 제외한 다른 실시양태와 비교할 때, 비교적 우수한 성능을 보여준다. Additionally, Embodiments 1, 11, and 12 also show relatively good performance when compared to other embodiments except Embodiment 1.
본 발명의 페이셜 마스크는, 인간의 신체 피부, 특히 얼굴 피부 위로의 국소 도포에 적합하다. 본 발명을 사용하면, 다양한 성분들의 침착 및 침투로 인하여, 매끄러움, 부드러움, 및 피부에 대한 촉촉한 느낌과 같은 피부 컨디셔닝 이점을 제공한다. The facial mask of the present invention is suitable for topical application to the human body skin, particularly the face skin. The use of the present invention provides skin conditioning benefits such as smoothness, softness, and moist feel to the skin due to deposition and penetration of various ingredients.
본 발명의 이점은, 유화된 액체 조성물에 포함된 피부 유효 작용제 및 만성 화이트닝제와 같은 구체적인 유효 작용제의 측면에서 본 발명의 마스크 조성물을 도포함으로써 제공된다. 본 발명의 마스크 조성물은, 영양 성분 및 기타 유효 작용제를 피부에 전달하는데 있어서 특히 유리하다. The advantages of the present invention are provided by applying the mask composition of the present invention in terms of specific effective agents such as a skin effective agent and a chronic whitening agent included in the emulsified liquid composition. The mask composition of the present invention is particularly advantageous in delivering nutrients and other active agents to the skin.
불용성 기판의 사용 없이 액체 조성물이 피부에 도포되는 경우에 비해, 오랜 기간 동안 수송 수단인 불용성 기판과 함께, 본 발명의 마스크 조성물을 사용하면, 이러한 작용제의 우수한 분포 및 침착, 및 경피 수송가능한 이러한 작용제의 우수한 침투를 제공하는 것으로 여겨진다. The use of the mask composition of the present invention, together with an insoluble substrate, which is a transport medium for a long period of time, compared to when the liquid composition is applied to the skin without the use of an insoluble substrate, results in excellent distribution and deposition of such agents, ≪ / RTI >
추가로, 낮은 통기성을 갖는 불용성 기판이 사용되는 경우, 피부로의 피부 유효 작용제의 보다 우수한 침투가 예상된다. 본 발명의 마스크 조성물은 또한 리프레싱 느낌 및 이완 느낌과 같이, 사용시 사용자에게 감정적인 이점을 제공한다. In addition, when insoluble substrates with low air permeability are used, better penetration of the skin active agent into the skin is expected. The mask compositions of the present invention also provide emotional benefits to the user at the time of use, such as a refreshing feel and a relaxed feel.
하나의 바람직한 실시양태에서, 마스크 조성물은, (a) 마스크 조성물을, 얼굴 피부의 대부분의 영역에 도포하는 단계; (b) 상기 마스크 조성물의 임의의 부분이 건조되는 것 이하의 시간 동안, 얼굴 피부 위에 상기 마스크 조성물을 정치시키는 단계; (c) 상기 마스크 조성물을 얼굴 피부로부터 제거하는 단계; 및 (d) 얼굴 피부 위에 남은 나머지 액체 조성물을 제거하는 단계에 의해, 얼굴 피부를 처치하기 위해 사용된다. In one preferred embodiment, the mask composition comprises: (a) applying a mask composition to a majority of the area of the facial skin; (b) allowing the mask composition to rest on the facial skin for a period of time less than any portion of the mask composition is dried; (c) removing the mask composition from the facial skin; And (d) removing the remaining liquid composition remaining on the facial skin.
마스크 조성물은 수성 액체 조성물로 적셔서, 피부 위에 부드럽게 놓음으로써 마스크가 얼굴 피부에 정합된다. 우수한 정합, 및 영양 성분과 기타 피부 유효 작용제의 균일한 분포를 위해서, 손가락 끝을 사용하여 마스크를 얼굴 피부쪽으로 누른다. The mask composition is wetted with an aqueous liquid composition, and the mask is matched to the facial skin by gently placing it on the skin. For good registration and uniform distribution of nutrients and other skin effective agents, use your fingertips to push the mask toward the facial skin.
Claims (5)
상기 페이셜 마스크 조성물이, 약용대황 10중량부, 중국개나리 10중량부, 황련 20중량부, 황금 25중량부, 감초 10중량부, 자초 20중량부, 보르네올 20중량부, 금은화 20중량부, 모란의 뿌리 껍질 10중량부, 적작약 20중량부, 활석 분필 20중량부, 볼루스 알바 10중량부, 아연 옥사이드 10중량부를 포함하는, 페이셜 마스크 조성물.The method according to claim 1,
The facial mask composition was prepared by mixing 10 parts by weight of medicinal rhubarb, 10 parts by weight of Chinese forages, 20 parts by weight of chrysanthemum, 25 parts by weight of gold, 10 parts by weight of licorice, 20 parts by weight of herbage, 20 parts by weight of borneol, 10 parts by weight of the root shell, 20 parts by weight of the antibacterial agent, 20 parts by weight of talc chalk, 10 parts by weight of Bolus alba, and 10 parts by weight of zinc oxide.
상기 페이셜 마스크 조성물이, 약용대황 15중량부, 중국개나리 15중량부, 황련 25중량부, 황금 32.5중량부, 감초 15중량부, 자초 25중량부, 보르네올 25중량부, 금은화 25중량부, 모란의 뿌리 껍질 15중량부, 적작약 30중량부, 활석 분필 30중량부, 볼루스 알바 15중량부, 아연 옥사이드 15중량부를 포함하는, 페이셜 마스크 조성물.The method according to claim 1,
The facial mask composition was prepared by mixing 15 parts by weight of medicinal rhubarb, 15 parts by weight of Chinese foreskin, 25 parts by weight of chrysanthemum, 32.5 parts by weight of gold, 15 parts by weight of licorice, 25 parts by weight of herbage, 25 parts by weight of borneol, 15 parts by weight of root shell, 30 parts by weight of anti-oxidative agent, 30 parts by weight of talc chalk, 15 parts by weight of Bolus alba, and 15 parts by weight of zinc oxide.
상기 페이셜 마스크 조성물이, 약용대황 12중량부, 중국개나리 11중량부, 황련 14중량부, 황금 28중량부, 감초 16중량부, 자초 24중량부, 보르네올 27중량부, 금은화 26중량부, 모란의 뿌리 껍질 16중량부, 적작약 33중량부, 활석 분필 28중량부, 볼루스 알바 14중량부, 아연 옥사이드 13중량부를 포함하는, 페이셜 마스크 조성물.The method according to claim 1,
The facial mask composition was prepared by mixing 12 parts by weight of medicinal rhubarb, 11 parts by weight of Chinese foreskin, 14 parts by weight of Rhodiola, 28 parts by weight of gold, 16 parts by weight of licorice, 24 parts by weight of pruning, 27 parts by weight of borneol, 16 parts by weight of root shell, 33 parts by weight of anti-oxidative agent, 28 parts by weight of talc chalk, 14 parts by weight of Bolus alba, and 13 parts by weight of zinc oxide.
상기 페이셜 마스크 조성물이, 약용대황 12중량부, 중국개나리 18중량부, 황련 22중량부, 황금 38중량부, 감초 14중량부, 자초 26중량부, 보르네올 28중량부, 금은화 22중량부, 모란의 뿌리 껍질 15중량부, 적작약 25중량부, 활석 분필 22중량부, 볼루스 알바 18중량부, 아연 옥사이드 17중량부를 포함하는, 페이셜 마스크 조성물.The method according to claim 1,
12 parts by weight of medicinal rhubarb, 18 parts by weight of Chinese forages, 22 parts by weight of phthalocyanine, 38 parts by weight of gold, 14 parts by weight of licorice, 26 parts by weight of herbage, 28 parts by weight of borneol, 15 parts by weight of root shell, 25 parts by weight of antibacterial agent, 22 parts by weight of talc chalk, 18 parts by weight of Bolus alba, and 17 parts by weight of zinc oxide.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020160107854A KR20180022430A (en) | 2016-08-24 | 2016-08-24 | Facial mask |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1020160107854A KR20180022430A (en) | 2016-08-24 | 2016-08-24 | Facial mask |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20180022430A true KR20180022430A (en) | 2018-03-06 |
Family
ID=61727646
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020160107854A KR20180022430A (en) | 2016-08-24 | 2016-08-24 | Facial mask |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR20180022430A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111166696A (en) * | 2019-12-19 | 2020-05-19 | 天津达仁堂京万红药业有限公司 | Plant extract soothing mask and preparation method thereof |
-
2016
- 2016-08-24 KR KR1020160107854A patent/KR20180022430A/en not_active Application Discontinuation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN111166696A (en) * | 2019-12-19 | 2020-05-19 | 天津达仁堂京万红药业有限公司 | Plant extract soothing mask and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104622776B (en) | A kind of cosmetic composition containing Chinese medicine extraction liquid | |
| CN103126972B (en) | Skin care composition with anti-aging and whitening effects | |
| CN102772355B (en) | Skin care composition with light aging resisting effect | |
| KR20180022430A (en) | Facial mask | |
| KR20180029578A (en) | Facial mask | |
| CN110787119A (en) | Antibacterial skin-care traditional Chinese medicine composition and preparation method and application thereof | |
| KR20180029579A (en) | Facial mask | |
| CN106265792B (en) | The medicine and its detection method of a kind of anti-skin photoage | |
| CN103372052B (en) | Traditional Chinese medicine compound preparation for treating leucoderma and preparation method thereof | |
| CN104434767A (en) | Tricholoma matsutake mask powder | |
| KR20170136954A (en) | Facial mask compositions | |
| KR20180044538A (en) | Facial mask | |
| KR20180033859A (en) | Facial mask | |
| CN113081921A (en) | Mask with effects of moisturizing, whitening and removing freckles and preparation method thereof | |
| KR20120043254A (en) | Cosmetic pack composition containing jeju scoria powder | |
| KR20180065111A (en) | Facial mask | |
| KR20180016788A (en) | Facial mask | |
| CN105997631A (en) | Ginseng facial mask with ultraviolet ray prevention effect | |
| KR20180035371A (en) | Facial mask | |
| CN106692458A (en) | Medicine composition for treating acnes as well as preparation method and application thereof | |
| CN111939107A (en) | Traditional Chinese medicine liquid with beautifying effect | |
| CN105560085A (en) | Tectoridin sunscreen skin care product | |
| CN103330743A (en) | Skin care composition with function of retaining youthful looks | |
| KR20180063599A (en) | Facial mask | |
| KR20180036186A (en) | Facial mask |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| E902 | Notification of reason for refusal | ||
| E601 | Decision to refuse application |